Aquestive Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Aquestive Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $31.81 million for the year ending 2020.

  • Aquestive Therapeutics, Inc. showed a decrease of -35.5% in Cash And Cash Equivalents At Carrying Value from 2019 to 2020.
  • This data is from Aquestive Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2021.
  • XBRL data for this metric is available from 2016 to 2020 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2016 to 2020), Aquestive Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 245.4%.
  • Historical annual values: Fiscal year 2020: $31.81 million | Fiscal year 2019: $49.33 million | Fiscal year 2018: $60.60 million | Fiscal year 2017: $17.38 million | Fiscal year 2016: $9.21 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: